Page last updated: 2024-10-22

altretamine and Female Genital Neoplasms

altretamine has been researched along with Female Genital Neoplasms in 3 studies

Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Neijt, JP1
Jansen, RL1
van der Burg, ME1
Verweij, J1
Stoter, G1
Fuller, AF1
Krane, IM1
Budzik, GP1
Donahoe, PK1

Reviews

1 review available for altretamine and Female Genital Neoplasms

ArticleYear
Advances in the chemotherapy of gynecologic cancer.
    Current opinion in oncology, 1994, Volume: 6, Issue:5

    Topics: Altretamine; Antineoplastic Agents; Clinical Trials as Topic; Endometrial Neoplasms; Etoposide; Fema

1994

Other Studies

2 other studies available for altretamine and Female Genital Neoplasms

ArticleYear
Cyclophosphamide, hexamethylmelamine, adriamycin and cisplatin combination chemotherapy in mixed mesodermal sarcoma of the female genital tract.
    European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:8

    Topics: Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxo

1987
Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay.
    Gynecologic oncology, 1985, Volume: 22, Issue:2

    Topics: Adenocarcinoma; Altretamine; Anti-Mullerian Hormone; Ascitic Fluid; Carcinoma; Chromatography, Affin

1985